Carlos Zamora

Carlos Zamora, MD, PhD is a Professor and Neuroradiology Division Chief at the UNC Department of Radiology. He graduated from Universidad de San Carlos (Guatemala) and earned his PhD at Kobe University (Japan). His career includes residencies at Johns Hopkins Hospital and international collaborations with Latin American societies. His expertise focuses on neuro-oncology, skull base pathology, and neuroradiology education. He pioneered descriptions of engorged medullary veins in neurosarcoidosis, a key diagnostic marker. He serves on editorial boards for American Journal of Neuroradiology and American Journal of Roentgenology. His teaching awards include the Charles A. Bream Award (2021) and multiple exhibit recognitions at ASNR conferences. Dr. Zamora emphasizes multidisciplinary tumor board collaboration and has contributed to over 100 peer-reviewed articles on neuroimaging techniques, vascular pathology, and diagnostic challenges.

Education:

• MD: Universidad de San Carlos de Guatemala
• PhD in Medical Sciences: Kobe University School of Medicine
• Diagnostic Radiology Residency: Johns Hopkins University
• Neuroradiology Fellowship: Johns Hopkins University

Research Focus: Neurosarcoidosis vascular imaging, neuroradiology education innovations, and diagnostic neuroradiology for complex CNS conditions. His team’s discovery of medullary vein engorgement has become a landmark finding in neurosarcoidosis diagnosis.

Awards:

• Charles A. Bream Award for Excellence in Teaching (2021)
• Multiple Certificate of Merit & Cum Laude awards at ASNR conferences
• Selected for 2023 AUR Radiology Management Program
• Tarheel Trauma Team Award (2022)

Professional Activities: Editorial board member (AJNR, AJR), international outreach programs with ARRS/ASNR, and leadership in neuroradiology education. He developed curriculum materials for imaging of pituitary adenomas, perivascular spaces, and inner ear anatomy.

Labs/Teams: Leads neuroradiology research within the UNC Department of Radiology, collaborating with neurosurgery and oncology teams on multidisciplinary tumor boards.